» Articles » PMID: 33406773

Formulation and Characterization of Alginate-Based Membranes for the Potential Transdermal Delivery of Methotrexate

Overview
Publisher MDPI
Date 2021 Jan 7
PMID 33406773
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study is to obtain and characterize of alginate-based membranes, as well as to choose the most suitable membrane type for the transdermal release of methotrexate. The paper presents the synthesis of four types of membranes based on alginate to which are added other copolymers (Carbopol, Tween, and Polyvinylpyrrolidone) as well as other components with different roles. Membranes and binary mixtures made between the components used in membrane synthesis and methotrexate are analyzed by thermogravimetric techniques, FTIR and UV spectroscopic techniques as well as SEM. The analyses aim to establish the type of membrane most indicated in the use of the controlled release of methotrexate, namely those membranes in which there are no interactions that could inactivate the active substance. Following these studies, it was concluded that membranes obtained from alginate/alginate and Tw can be used for methotrexate release. The membrane obtained from alginate and carbopol was excluded from the beginning because it is not homogeneous. Regarding the AGP-MTX membrane, it presents interactions with the active substance, carboxylate group interactions argued by TGA and FTIR studies, and interactions that occur in aqueous medium.

Citing Articles

Novel methotrexate long-acting system using ambroxol coating and hydroxypropyl methylcellulose encapsulation for preferential and enhanced lung cancer efficiency.

Abdullah S, Altwaijry N, Alnakhli M, ALenezi G, Al-Masud A, Henidi H PLoS One. 2025; 20(1):e0314941.

PMID: 39821171 PMC: 11737749. DOI: 10.1371/journal.pone.0314941.


Methylene Blue Solid Alginate Gels for Photodynamic Therapy: The Peculiarities of Production and Controlled Release of the Dye.

Solovieva A, Kopylov A, Cherkasova A, Shershnev I, Kaplin V, Timofeeva V Polymers (Basel). 2024; 16(19).

PMID: 39408531 PMC: 11478748. DOI: 10.3390/polym16192819.


Antitumoral-Embedded Biopolymeric Spheres for Implantable Devices.

Grumezescu V, Gherasim O, Galateanu B, Hudita A Pharmaceutics. 2024; 16(6).

PMID: 38931875 PMC: 11207774. DOI: 10.3390/pharmaceutics16060754.


Synthesis and Characterization of Polymer-Based Membranes for Methotrexate Drug Delivery.

Bradu I, Vlase T, Bunoiu M, Gradinaru M, Pahomi A, Bajas D Polymers (Basel). 2023; 15(21).

PMID: 37960005 PMC: 10649268. DOI: 10.3390/polym15214325.


Polymeric nanocomposite hydrogel scaffold for jawbone regeneration: The role of rosuvastatin calcium-loaded silica nanoparticles.

Adel I, ElMeligy M, Amer M, Elkasabgy N Int J Pharm X. 2023; 6:100213.

PMID: 37927584 PMC: 10622845. DOI: 10.1016/j.ijpx.2023.100213.


References
1.
Martau G, Mihai M, Vodnar D . The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector-Biocompatibility, Bioadhesiveness, and Biodegradability. Polymers (Basel). 2019; 11(11). PMC: 6918388. DOI: 10.3390/polym11111837. View

2.
Kishore R, Pappenberger A, Bauer Dauphin I, Ross A, Buergi B, Staempfli A . Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. J Pharm Sci. 2010; 100(2):721-31. DOI: 10.1002/jps.22290. View

3.
Qadariyah L, Mahfud , Sumarno , Machmudah S, Wahyudiono , Sasaki M . Degradation of glycerol using hydrothermal process. Bioresour Technol. 2011; 102(19):9267-71. DOI: 10.1016/j.biortech.2011.06.066. View

4.
Smolen J, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017; 76(6):960-977. DOI: 10.1136/annrheumdis-2016-210715. View

5.
Singh J, Saag K, Bridges Jr S, Akl E, Bannuru R, Sullivan M . 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2015; 68(1):1-26. DOI: 10.1002/art.39480. View